Literature DB >> 33984744

Inflammatory Biomarkers Correlate with Time Evolution in Cerebral Venous Thrombosis.

Leonor Dias1, Maria João Pinto2, Pedro Castro2, Marta Carvalho2.   

Abstract

OBJECTIVES: We aimed to analyse the relationship between specific inflammatory biomarkers' levels and the temporal pattern of cerebral venous thrombosis (CVT) symptoms.
MATERIALS AND METHODS: We performed a retrospective study of adult CVT patients admitted between Jan 01 2006 and Dec 31 2019. We excluded patients with infection at admission, autoimmune, inflammatory or haematological disorders. We evaluated serum inflammatory biomarkers at admission: C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), absolute neutrophil count, absolute lymphocyte count, platelet count, monocyte count, neutrophile-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR), bilirubin and monocyte-to-HDL ratio (M-HDLR). These were evaluated according to the time from symptom onset (acute, subacute or chronic).
RESULTS: We included 78 patients with CVT (mean age 41 ± 13 years). Neutrophil count (p = 0.017), monocyte (p = 0.024), CRP (p = 0.004), NLR (p<0.001) and LMR (p = 0.004) showed significant variation with CVT duration. Acute onset CVT exhibited higher absolute neutrophil count and NLR but lower LMR. The subacute group had higher monocyte values, and the chronic phase patients displayed higher LMR, but lower CRP. ESR, PLR and M-HDLR showed a tendency to decrease in the chronic phase. We did not observe any statistical difference between the duration of symptoms and levels of bilirubin.
CONCLUSIONS: CVT patients present a differential inflammatory pattern along the time course of the disease: higher NLR and lower LMR in acute phase, and higher LMR and lower CRP level during the chronic phase. These differences may help to ascertain the onset of poorly defined symptoms and provide input regarding anticoagulation management.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cerebral venous thrombosis; Serum inflammatory biomarkers

Year:  2021        PMID: 33984744     DOI: 10.1016/j.jstrokecerebrovasdis.2021.105844

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  3 in total

1.  Effects of low molecular weight heparin combined with hyperbaric oxygen on neurologic function and coagulation factors in patients with intracranial venous thrombosis.

Authors:  Bo-Feng Liu; Xiao-Hui Liu; Xiao-Hui Dong; Ning Ma; Hui-Ping Zhang; Li-Li Jiang; Yan-Qing Liu
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

Review 2.  Inflammation in Cerebral Venous Thrombosis.

Authors:  Jiayue Ding; Baoying Song; Xiran Xie; Xaingyu Li; Zhiying Chen; Zhongao Wang; Liqun Pan; Duo Lan; Ran Meng
Journal:  Front Immunol       Date:  2022-04-04       Impact factor: 8.786

Review 3.  Inflammation and Severe Cerebral Venous Thrombosis.

Authors:  Shuyuan Hu; Hangil Lee; Haiping Zhao; Yuchuan Ding; Jiangang Duan
Journal:  Front Neurol       Date:  2022-07-22       Impact factor: 4.086

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.